15O-water PET MPI may be a promising way to personalize treatment for patients with a history of bypass surgery who are still experiencing chest pain.
That is the short version of the conclusion in a recent and very insightful article in the latest edition of European Heart Journal published by European Society of Cardiology.
It is bright minds from Aarhus University Hospital who authored the article.
Aarhus University Hospital is home to some of the world’s leading experts on 15O-water PET and at MedTrace we are excited to follow closely how 15O-water is investigated and what information it may be able to provide healthcare professionals and patients.
“Myocardial perfusion imaging by 15O-H2O positron emission tomography predicts clinical revascularization procedures in symptomatic patients with previous coronary artery bypass graft” was written by:
Mazen Vester (1,*)
Simon Madsen (1,*)
Mette Louise Gram Kjærulff (1)
Lars Poulsen Tolbod (1)
Bent Roni Ranghøj Nielsen (2)
Steen Dalby Kristensen (2,3)
Evald Høj Christiansen (2,3)
Per Hostrup Nielsen (4)
Jens Sörensen (1,5)
Lars Christian Gormsen (1,3)
*M.V. and S.M. contributed equally to the article.
(1) Department of Nuclear Medicine and PET-Centre, Aarhus University Hospital
(2) Department of Cardiology, Aarhus University Hospital
(3) Department of Clinical Medicine, Aarhus University
(4) Department of Thoracic Surgery, Aarhus University Hospital
(5) Department of Surgical Sciences, Nuclear Medicine and PET, Uppsala University
Read the full article here: Myocardial perfusion imaging by 15O-H2O positron emission tomography predicts clinical revascularization procedures in symptomatic patients with previous coronary artery bypass graf